How the availability of anti-C5a agents could change the management of ANCA-associated Vasculitis
Background: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a cluster of potentially life-threatening disorders often involving the kidney with a necrotizing crescentic glomerulonephritis with scanty deposition of immunoglobulins and complement. Historically the role of co...
Saved in:
Main Authors: | Dario Roccatello (Author), Roberta Fenoglio (Author), Valentina Oddone (Author), Savino Sciascia (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020) -
Antiphospholipid syndrome and kidney involvement
by: Emanuele De Simone, et al.
Published: (2023) -
Epidemiology of ANCA associated vasculitis
by: Wenche Koldingsnes, et al.
Published: (2008) -
Anti-idiotype antibodies in immune regulation of ANCA associated vasculitis
by: Pradhan Vandana, et al.
Published: (2009) -
Vasculitis ANCA y esclerosis sistémica
by: Maite Hurtado, et al.
Published: (2016)